{
    "eid": "2-s2.0-84947864677",
    "title": "Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease",
    "cover-date": "2015-11-02",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Neurology (clinical)",
            "@code": "2728"
        },
        {
            "$": "General Neuroscience",
            "@code": "2800"
        }
    ],
    "keywords": [
        "Arab",
        "Asia",
        "fluctuations",
        "non-motor",
        "Parkinson's disease",
        "screening tools",
        "wearing-off"
    ],
    "authors": [
        "Roongroj Bhidayasiri"
    ],
    "citedby-count": 20,
    "ref-count": 100,
    "ref-list": [
        "Clinical spectrum of levodopa-induced complications",
        "An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines",
        "Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology",
        "Identification of motor and nonmotor wearing-off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment",
        "The levodopa wearing-off phenomenon in Parkinson's disease: Pharmacokinetic considerations",
        "The patient card questionnaire to identify wearing-off in Parkinson disease",
        "Levodopa-related wearing-off in Parkinson's disease: Identification and management",
        "Wearing-off scales in Parkinson's disease: Critique and recommendations",
        "The movement disorder society evidence-based medicine review update: Treatments for the motor symptoms of Parkinson's disease",
        "Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease",
        "National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG35",
        "Canadian guidelines on Parkinson's disease executive summary",
        "Catechol-O-methyltransferase Val158Met polymorphism: Modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease",
        "Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan",
        "Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population",
        "LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study",
        "Motor phenotype of LRRK2-associated Parkinson's disease: A tunisian longitudinal study",
        "Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism",
        "Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease",
        "Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease",
        "When do levodopa motor fluctuations first appear in Parkinson's disease?",
        "The modern pre-levodopa era of Parkinson's disease: Insights into motor complications from sub-Saharan Africa",
        "Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks",
        "Prognosis of Parkinson's disease: Time to stage III, IV, V and to motor fluctuations",
        "What factors influence motor complications in parkinson disease? A 10-year prospective study",
        "The motor phenotype of Parkinson's disease in relation to age at onset",
        "Early development of levodopa-induced dyskinesias and response fluctuations in young-onset parkinson\u2019s disease",
        "Levodopa pharmacokinetics and dyskinesia: Are there sex-related differences?",
        "Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature",
        "Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial",
        "Patient Relat Outcome Meas",
        "The COMT Val158Met polymorphism as an associated risk factor for Parkinson's disease in Asian rather than Caucasian populations",
        "Val158Met polymorphism of COMT gene and Parkinson\u2019s disease risk in Asians",
        "Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease",
        "Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: A multi-center registry survey in mainland China",
        "Clinical features and varieties of non-motor fluctuations in Parkinson's disease: A Japanese multicenter study",
        "Levodopa induced motor complications in Thai Parkinson's disease patients",
        "End-of-dose wearing off in parkinson disease: A 9-question survey assessment",
        "Nonmotor fluctuations in Parkinson's disease: Frequent and disabling",
        "Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease",
        "Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?",
        "Prevalence of nocturia in parkinson's disease patients from various ethnicities",
        "Nocturnal journey of body and mind in Parkinson's disease: The manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD study",
        "Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications",
        "Development of a patient questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease",
        "The Q10 questionnaire for detection of wearing-off phenomena in Parkinson's disease",
        "Translation and linguistic validation of the Japanese version of the Wearing-off Questionnaires (WOQ-19 and WOQ-9)",
        "A validation study of the Chinese wearing off questionnaire 9-symptom for Parkinson's disease",
        "A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia",
        "Motor complications in Parkinson disease: Clinical manifestations and management",
        "A multicenter double\u2010blind placebo\u2010controlled trial of pergolide as an adjunct to sinemet\u00ae in Parkinson's disease",
        "Neurology",
        "A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease",
        "Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study",
        "Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study",
        "Mov Disord",
        "Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study",
        "Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial",
        "Treatment of parkinson's disease in thailand: Review of the literature and practical recommendations",
        "A reassessment of risks and benefits of dopamine agonists in Parkinson's disease",
        "An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson's disease",
        "Meta-analysis of the efficacy and safety of long-acting non-ergot dopamine agonists in Parkinson's disease",
        "The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study",
        "Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: Results from an open-label study",
        "Efficacy and safety of extended-versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: A double-blind, randomized trial",
        "Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson's disease",
        "Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients",
        "J Clin Neurol",
        "COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease",
        "A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: The PRESTO study",
        "Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): A randomised, double-blind, parallel-group trial",
        "Zonisamide: A new drug for Parkinson's disease",
        "Mov Disord",
        "Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations",
        null,
        "Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study",
        "Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease",
        "Rapid treatment of \"wearing off\" in Parkinson's disease",
        "Effective delivery of apomorphine in the management of parkinson disease: Practical considerations for clinicians and parkinson nurses"
    ],
    "affiliation": [
        {
            "affiliation-city": "Riyadh",
            "affilname": "King Fahad Medical City",
            "affiliation-country": "Saudi Arabia"
        },
        {
            "affiliation-city": "Manila",
            "affilname": "University of the Philippines College of Medicine",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Taipei",
            "affilname": "Chang Gung Memorial Hospital",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Hangzhou",
            "affilname": "Zhejiang University School of Medicine",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Singapore City",
            "affilname": "National Neuroscience Institute of Singapore",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Bangkok Hospital Medical Center",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Seoul National University",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Tokyo",
            "affilname": "Juntendo University School of Medicine",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Innsbruck",
            "affilname": "Medizinische Universitat Innsbruck",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "Chinese University of Hong Kong",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Petaling Jaya, Selangor",
            "affilname": "Jalan Lagoon Selatan",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Quezon City",
            "affilname": "St. Luke\u2019s Medical Center-Quezon City",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Jakarta",
            "affilname": "National Brain Center Hospital",
            "affiliation-country": "Indonesia"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Chulalongkorn University"
    ]
}